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Abstract The World Health Organization (WHO) has
recognised all Cronobacter species as human pathogens.
Among premature neonates and immunocompromised in-
fants, these infections can be life-threatening, with clinical
presentations of septicaemia, meningitis and necrotising en-
terocolitis. The neurological sequelae can be permanent and
the mortality rate as high as 40–80 %. Despite the highlighted
issues of neonatal infections, the majority of Cronobacter in-
fections are in the elderly population suffering from serious
underlying disease or malignancy and include wound and uri-
nary tract infections, osteomyelitis, bacteraemia and
septicaemia. However, no age profiling studies have speciated
or genotyped theCronobacter isolates. A clinical collection of
51 Cronobacter strains from two hospitals were speciated and
genotyped using 7-loci multilocus sequence typing (MLST),
rpoB gene sequence analysis, O-antigen typing and pulsed-
field gel electrophoresis (PFGE). The isolates were predomi-
nated by C. sakazakii sequence type 4 (63 %, 32/51) and
C. malonaticus sequence type 7 (33 %, 17/51). These had
been isolated from throat and sputum samples of all age
groups, as well as recal and faecal swabs. There was no
apparent relatedness between the age of the patient and the
Cronobacter species isolated. Despite the high clonality of
Cronobacter, PFGE profiles differentiated strains across the
sequence types into 15 pulsotypes. There was almost com-
plete agreement between O-antigen typing and rpoB gene
sequence analysis and MLST profiling. This study shows
the value of applying MLST to bacterial population studies
with strains from two patient cohorts, combined with PFGE
for further discrimination of strains.
Introduction
The Cronobacter genus belongs to the family Enterobacteria-
ceae and consists of seven species:C. sakazakii,C.malonaticus,
C. muytjensii, C. turicensis, C. dublinensis, C. universalis and
C. condimenti [1, 2]. In 2002, the International Commission on
Microbiological Specifications for Foods (ICMSF) classified
Cronobacter as pathogenic organisms to a restricted popula-
tion, endangering their lives and causing serious long-term con-
sequences [3]. The World Health Organization (WHO) has
recognised all Cronobacter species as microorganisms patho-
genic for human beings [4]. Among premature neonates and
immunocompromised infants, these infections can be life-
threatening, with clinical presentations of septicaemia, menin-
gitis and necrotising enterocolitis. The neurological sequelae
can be permanent and the mortality rate can be as high as 40–
80 % [5]. Despite the highlighted issues of neonatal infections,
the majority of Cronobacter infections are in the adult popula-
tion, especially those suffering from serious underlying disease
or malignancy [6]. Cronobacter species are also part of the
normal flora carriage [7–9].
The first reported age-profiled data was for 819
Cronobacter bacteraemia cases in England and Wales be-
tween 1992 and 2007 [4]. The majority (91 %) of bacteraemia
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cases were patients >15 years in age. Holý et al. reported
the age profile of Cronobacter carriage from a survey of
>45,000 patients from two hospitals sampled from 2005
to 2011 [9]. The organism was isolated from every age
group, with a higher frequency in children less than
14 years of age. The majority of Cronobacter spp. isolates
were from throat swabs, followed by urine, tracheal aspi-
rates, bronchoalveolar lavage, cannulae and sputum sam-
ples. Patrick et al. also reported an age profile for
Cronobacter infections from an earlier period (2003–
2009), which confirmed its prominence in the adult pop-
ulation, especially in urinary tract infections (UTIs) [6].
However, none of these age profiling studies speciated or
genotyped the Cronobacter isolates. To date, over 1000
Cronobacter strains have been genotyped according to a
7-loci multilocus sequence typing (MLST) scheme [10].
This genotyping has revealed a prevalence of C. sakazakii
clonal complex 4 with neonatal meningitis cases and
C. malonaticus clonal complex 7 with adult infections
[10–12]. Whole genome phylogenetic analysis (164 ge-
nomes) has confirmed the use of fusA for Cronobacter
speciation [10, 13].
This study aimed to address this lack of knowledge using
the collection of 51 clinical Cronobacter strains, which in-
cluded those from the study by Holý et al. [9]. These strains
were speciated and genotyped using 7-loci MLST, rpoB gene
sequence analysis, O-antigen typing and pulsed-field gel elec-
trophoresis (PFGE).
Materials and methods
Bacterial strains and cultivation
Fifty-one clinical Cronobacter strains were used in this study.
The strains had been collected during a survey ofCronobacter
carriage by patients from two hospitals, during a 6-year period
fromMay 2007 to August 2013. This includes strains isolated
in the previous study by Holý et al. [9]. Patient information
such as age, sex, clinical presentation, isolated site and date of
isolation are given in Table 1. Bacterial strains were routinely
cultivated on tryptone soya agar (Fluka, UK) at 37 °C
overnight.
Phenotyping
Cronobacter isolates were phenotyped using the ID 32E
kit (bioMérieux), according to the manufacturer’s instruc-
tions. The resultant phenotypic profiles were compared to
the bioMérieux online database at https://apiweb.
biomerieux.com.
PFGE of Cronobacter isolates
PFGE analysis of Cronobacter isolates was as previously de-
scribed by Caubilla-Barron et al. [14] using the two restriction
enzymes Xbal and Spel (Promega, UK). The bands were sep-
arated using a CHEF-DR II System (Bio-Rad, Belgium) at
14 °C, 6 V for 20 h with initial and final switch of 5 and
50 s, respectively. The DNA band profiles were analysed
using BioNumerics software version 7.1 (AppliedMaths, Bel-
gium). The banding patterns obtained from the PFGE for both
XbaI and SpeI were combined within the Bionumerics soft-
ware and analysed by the unweighted pair-group method
using arithmetic averages (UPGMA). Isolates with band sim-
ilarity values of less than 95 % were considered to be non-
clonal [15].
Molecular serotyping of Cronobacter O-antigens
Cronobacter serotypes were determined using the multiplex
polymerase chain reaction (PCR) assay as described by Jarvis
et al. and Sun et al. [16, 17]. The allocated serotypes were
uploaded to the Cronobacter PubMLST database for open
access; http://PubMLST.org/cronobacter/.
DNA extraction
DNA was extracted from the target strains using the
GenElute™ kit (Sigma, UK), according to the manufacturer’s
instructions. The DNA concentration was confirmed using a
NanoDrop® ND-2000 UV–vis spectrometer (Thermo Scien-
tific, UK), and the DNAwas stored at −20 °C for 6 months.
rpoB allele sequence analysis
rpoB allele profiling was performed as described by Brady
et al. [18]. PCR products were visualised on a 1 % agarose
gel stained with SYBR Safe. The PCR product (637 bp) was
sequenced and aligned with additional sequences from the
Cronobacter PubMLST database in MEGA (Molecular Evo-
lutionary Genetics Analysis) software version 5.2 [19] using
the ClustalWalgorithm. rpoB alleles were allocated numbered
profiles according to the PubMLST database and were
uploaded for open access.
MLST
MLST was performed as previously described by Baldwin
et al. [20] and as given on the Cronobacter PubMLST open
access database (http://www.pubmlst.org/cronobacter/). The
seven housekeeping genes amplified were ATP synthase
beta chain (atpD), elongation factor G (fusA), glutaminyl-
tRNA synthetase (glnS), glutamate synthase large subunit
(gltB), DNA gyrase subunit B (gyrB), translation initiation
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Table 1 Source of Cronobacter strains used in this study
Strain number Hospital Department Patient age (years) Patient sex Isolation date Isolation site
1830 Olomouc Paediatrics <1 Male 09/05/2007 Throat swab
1829 Olomouc Paediatrics 1 Male 04/06/2007 Throat swab
1828 Olomouc Paediatrics 2 Male 12/10/2007 Nose swab
1831 Olomouc Paediatrics 3 Male 06/06/2007 Throat swab
1832 Olomouc Paediatrics 3 Female 27/03/2009 Throat swab
1999 Olomouc Paediatrics 3 Male 30/01/2013 Throat swab
2020 Olomouc Paediatrics 5 Female 26/05/2013 Stool
1835 Olomouc Paediatrics 6 Male 30/03/2012 Throat swab
2015 Olomouc Paediatrics 7 Female 16/08/2013 Throat swab
2014 Olomouc Paediatrics 8 Male 08/04/2013 Throat swab
1917 Olomouc Paediatrics 15 Male 28/10/2012 Throat swab
1834 Olomouc Paediatrics 16 Male 31/05/2010 Throat swab
2004 Olomouc Paediatrics 17 Female 02/03/2013 Throat swab
1827 Olomouc Internal Medicine III 76 Female 09/10/2007 Cannula
1833 Olomouc CMPa 5 Male 11/01/2010 Stool
1838 Olomouc AICUb 63 Female 10/04/2012 Sputum
1998 Prostějov Internal Medicine (A) 49 Female 22/01/2013 Sputum
2008 Prostějov Internal Medicine (A) 68 Male 12/03/2013 Sputum
2011 Prostějov Internal Medicine (A) 68 Male 31/03/2013 USCd
2006 Prostějov Internal Medicine (A) 70 Female 28/02/2013 Sputum
2007 Prostějov Internal Medicine (A) 70 Female 06/03/2013 Sputum
2022 Prostějov Internal Medicine (A) 70 Female 06/03/2013 Sputum
1842 Prostějov Internal Medicine (A) 72 Female 27/06/2012 Sputum
2005 Prostějov Internal Medicine (A) 73 Female 24/02/2013 Sputum
2021 Prostějov Internal Medicine (A) 76 Female 07/04/2013 Sputum
1841 Prostějov Internal Medicine (A) 79 Female 18/06/2012 Sputum
2003 Prostějov Internal Medicine (A) 83 Male 20/02/2013 Sputum
1915 Prostějov Internal Medicine (A) 84 Female 18/10/2012 Sputum
1996 Prostějov Internal Medicine (A) 84 Female 14/01/2013 Sputum
2010 Prostějov- Internal Medicine (A) 84 Female 12/03/2013 Throat swab
2019 Prostějov Internal Medicine (A) 87 Male 10/05/2013 Sputum
2001 Prostějov Internal Medicine (B) 68 Male 29/01/2013 SOCe
2000 Prostějov Internal Medicine (B) 71 Male 03/02/2013 Rectal Swab
2002 Prostějov Internal Medicine (B) 77 Male 19/02/2013 Sputum
1916 Prostějov Internal Medicine (B) 84 Male 06/11/2012 Sputum
2013 Prostějov Internal Medicine (B) 91 Female 04/04/2013 Sputum
2012 Prostějov Internal Medicine (C) 70 Male 04/04/2013 Sputum
2009 Prostějov Internal Medicine (C) 77 Female 16/03/2013 Tongue swab
1903 Prostějov Internal Medicine—ICU 59 Male 24/08/2012 Sputum
1902 Prostějov Internal Medicine—ICU 69 Male 21/08/2012 Sputum
1901 Prostějov Internal Medicine—ICU 82 Male 15/08/2012 Sputum
1997 Prostějov ICUc 65 Male 21/01/2013 Sputum
1839 Prostějov ICU 73 Female 12/06/2012 SPEGf
1840 Prostějov ICU 80 Female 19/06/2012 Sputum
1836 Prostějov Surgery 63 Male 23/05/2012 Wound swab
1837 Prostějov Surgery 85 Female 25/05/2012 Wound swab
1914 Prostějov Infectious Diseases 69 Male 02/10/2012 Sputum
2018 Prostějov Infectious Diseases 72 Male 05/05/2013 Sputum
2016 Prostějov AICU 27 Male 18/04/2013 Sputum
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factor IF-2 (infB) and phosphoenolpyruvate synthase (ppsA).
For multilocus sequence analysis (MLSA), concatenated se-
quences (3036 bp total length) were aligned inMEGAversion
5.2 using the ClustalW algorithm.
Results
A total of 51 Cronobacter strains were characterised by sev-
eral phenotyping and genotyping methods. Presumptive iden-
tification using ID 32E phenotyping identified 49 isolates as
Enterobacter sakazakii, one strain (1838) as Pantoea spp. and
the remaining strain (1841) as E. cloacae. Since the
bioMérieux ID 32E online database does not recognise the
Cronobacter genus, the strains could not be further identified
using this method.
Using the fusA sequence analysis and comparison with the
Cronobacter PubMLST database identified the 51 strains as
primarily C. sakazakii (33/51), followed by C. malonaticus
(17/51) and one C. muytjensii strain. The strains were then
further genotyped using the 7-loci MLST scheme. This sup-
ported the species identification-based fusA sequence analysis,
and further subtyped the isolates (Table 2). The C. sakazakii
strains were from two sequence types; ST4 (32/51, 63 %) and
ST64 (1/51, 2 %). All the C. malonaticus strains were ST7
(17/51, 33 %) and the single C. muytjensii isolate was ST28
(2 %).
The identification of strains using rpoB sequence analysis
[18] and comparison with rpoB sequences in the Cronobacter
PubMLST database agreed with species designation using
fusA allele sequence analysis (Table 2). There were four dif-
ferent rpoB profiles, 1, 18, 35 and 36, which correlated with
their 7-loci sequences types. All C. sakazakii ST4 and ST64
strains were rpoB profiles 1 and 35, respectively. The
C. malonaticus ST7 strains were rpoB profile 18 and
C. muytjensii ST28 was rpoB profile 36. See Table 2 for more
information.
Comparison with serotyping profiling showed a strong cor-
relation between some sequence types and serotypes. O-
serotype C. sakazakii O:2 corresponded with C. sakazakii
ST4. The association was not exclusive however, as
C. sakazakii ST64 (strain 1995) was also serotypeC. sakazakii
O:2. In addition, the serotype of all (n=17) C. malonaticus
ST7 strains corresponded with the two designated serotypes
C. malonaticus O:2 and C. sakazakii O:6 according to the
schemes of Jarvis et al. and Sun et al., respectively [16, 17].
Based on fusA speciation, C. malonaticus O:2 was given as
the serotype for these strains (Table 3). No serotype could be
determined for the C. muytjensii strain as no PCR products
were obtained with either PCR serotyping scheme.
PFGE was used to ascertain whether the strains in each
sequence type (i.e. C. sakazakii ST4 and C. malonaticus
ST7) could be further distinguished and whether this could
be used to profile the strains from the two hospitals. Using
the restriction enzymeXbaI,C. sakazakii strains gave 12 to 17
DNA fragments per strain, whereas C. malonaticus strains
gave 8 to 10 bands (Fig. 1). Comparable numbers of frag-
ments were obtained using SpeI: 14 to 17 bands for
C. sakazakii strains and 14 to 16 bands for C. malonaticus
Table 1 (continued)
Strain number Hospital Department Patient age (years) Patient sex Isolation date Isolation site
2017 Prostějov AICU 27 Male 22/04/2013 Sputum
1995 Prostějov Outpatient 50 Male 10/01/2013 Sputum
aCMP Clinical and Molecular Pathology
bAICU Anaesthesiology and Intensive Care Unit
c ICU Intensive Care Unit
dUSC Urine suction catheter
e SOC Swab of the oral cavity
f SPEG Smear from area of percutaneous endoscopic gastrostomy
Table 2 Number of isolated Cronobacter strains from various hospital
departments
Hospital Department Number of Cronobacter
strains isolated
Olomouc Paediatrics 13
Internal Medicine 1
AICUa 1
Pathology 1
Prostějov Internal Medicine 22
Internal Medicine—ICUb 3
Surgery 2
ICU 3
Infectious Diseases 2
AICU 2
Outpatient 1
Total 51
aAICU Anaesthesiology and Intensive Care Unit
b ICU Intensive Care Unit
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strains. The XbaI restriction enzyme separated the collection
into 16 pulsotypes: ten for C. sakazakii , five for
C. malonaticus and one for C. muytjensii, while the SpeI re-
striction enzyme divided the collection into 14 pulsotypes:
Table 3 Speciation and genotyping of Cronobacter spp. from two hospitals
Strain Hospital Species Pulsotype rpoB allele fusA allele Serotype Sequence type
2021 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2022 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1901 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1915 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1996 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1837 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1841 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1842 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2003 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2005 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2007 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2010 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2016 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2019 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
2017 Prostějov C. sakazakii 12 1 1 CS O:2 ST4
1916 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
1840 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
2000 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
2001 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
2002 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
2009 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
2011 Prostějov C. sakazakii 7 1 1 CS O:2 ST4
1917 Olomouc C.malonaticus 4 18 7 CMal O:2 ST7
1999 Olomouc C.malonaticus 4 18 7 CMal O:2 ST7
2004 Olomouc C.malonaticus 4 18 7 CMal O:2 ST7
2015 Olomouc C.malonaticus 4 18 7 CMal O:2 ST7
2014 Olomouc C.malonaticus 4 18 7 CMal O:2 ST7
2020 Olomouc C.malonaticus 4 18 7 CMal O:2 ST7
1828 Olomouc C.malonaticus 5 18 7 CMal O:2 ST7
1829 Olomouc C.malonaticus 5 18 7 CMal O:2 ST7
1830 Olomouc C.malonaticus 5 18 7 CMal O:2 ST7
1831 Olomouc C.malonaticus 5 18 7 CMal O:2 ST7
1832 Olomouc C.malonaticus 5 18 7 CMal O:2 ST7
1903 Prostějov C. sakazakii 10 1 1 CS O:2 ST4
1998 Prostějov C. sakazakii 10 1 1 CS O:2 ST4
2006 Prostějov C. sakazakii 10 1 1 CS O:2 ST4
2008 Prostějov C. sakazakii 10 1 1 CS O:2 ST4
1833 Olomouc C.malonaticus 3 18 7 CMal O:2 ST7
1834 Olomouc C.malonaticus 3 18 7 CMal O:2 ST7
1835 Olomouc C.malonaticus 3 18 7 CMal O:2 ST7
1902 Prostějov C. sakazakii 11 1 1 CS O:2 ST4
1997 Prostějov C. sakazakii 11 1 1 CS O:2 ST4
1914 Prostějov C.malonaticus 1 18 7 CMal O:2 ST7
2018 Prostějov C.malonaticus 1 18 7 CMal O:2 ST7
1827 Olomouc C.malonaticus 2 18 7 CMal O:2 ST7
2013 Prostějov C. sakazakii 8 1 1 CS O:2 ST4
2012 Prostějov C. sakazakii 9 1 1 CS O:2 ST4
1839 Prostějov C. sakazakii 13 1 1 CS O:2 ST4
1836 Prostějov C. sakazakii 14 1 1 CS O:2 ST4
1995 Prostějov C. sakazakii 15 35 8 CS O:2 ST64
1838 Olomouc C. muytjensii 6 36 24 No PCR product ST28
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eight for C. sakazakii, five for C. malonaticus and one for
C. muytjensii. Combining the PFGE profiles generated with
the restriction enzymes XbaI and SpeI grouped the 51 strains
into a total of 15 pulsotypes: nine for C. sakazakii, five for
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Fig. 1 Combined XbaI and SpeI pulsed-field gel electrophoresis (PFGE)
profiles of 51 Cronobacter strains. Infect D Infectious Diseases, IMIII
Internal Medicine III, Paed Paediatric, CMP Clinical and Molecular
Pathology, AICU Anaesthesiology and Intensive Care Unit, IMA IMB
IMC Internal Medicine A, B, C, respectively, ICU Intensive Care Unit,
OP Outpatient, TS throat swab, NS nasal swab, ToS tongue swab, OCS
oral cavity swab, RS rectal swab, USC urine suction catheter,WS wound
swab, SPEG smear from area of percutaneous endoscopic gastrostomy
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C. malonaticus and one for C. muytjensii. Strains of the same
sequence type from different hospital departments were dis-
tinguishable by PFGE and are considered in more detail
below.
The isolates from Olomouc hospital formed four distin-
guishable C. malonaticus pulsotypes (PT2 to 5) and one
C. muytjensii pulsotype (PT6), which were recovered from
different age groups of patients from four hospital depart-
ments. PT2was oneC. malonaticus ST7 strain (1827) isolated
in the Internal Medicine Department from the intravenous
cannula of a 76-year-old patient in 2007. PT3 was composed
of three C. malonaticus ST7 strains (1834, 1835, 1833), two
of which were isolated from the Paediatric Department and
one was from the Clinical and Molecular Pathology Depart-
ment. The three PT3 strains had been isolated over a 2-year
period from throat and stool samples of patients under 16 years
of age. The six isolates in PT4 were all C. malonaticus ST7
strains. Five had been isolated from the Paediatric Department
over a 10-month period from throat swabs and one from a
stool sample. The patient ages ranged from 3 to 17 years
old. The majority (4/5) of PT5 strains were isolated from the
throat and one from nose from the same Paediatric Depart-
ment. These strains were also C. malonaticus ST7 and had
been collected over a period of 2 years. The patient ages
ranged from 2 months to 3 years. C. muytjensii ST28 strain
1838was in a unique pulsotype (PT6). This strain was isolated
in 2012 at the Anaesthesiology and Intensive Care Unit, from
the sputum of a 63-year-old patient.
The isolates from Prostějov hospital were recovered from
seven departments and were clustered in ten distinguishable
Cronobacter pulsotypes (Table 3). PT1 was the only
C. malonaticus pulsotype (strains 1914 and 2018). These were
both C. malonaticus ST7 strains which were isolated from
patients’ sputum at the Infectious Disease Department. The
collection was over a 7-month period, and the patients were
69 and 72 years in age. All the remaining isolates were strains
of C. sakazakii, which formed nine pulsotypes (PT7 to 15).
Eight of these pulsotypes (PT7 to 14) were composed of 32
strains of C. sakazakii ST4. PT15 was composed of one
C. sakazakii ST64 strain (1995). Most of the 15 C. sakazakii
ST4 strains in PT12 were isolated from sputum except strains
1837 and 2010, which were isolated from a wound swab and
throat swab, respectively. This pulsotype was collected over
period of about 1 year and the patients ages ranged from 27 to
87 years. In PT12, 12 isolates were collected from the Internal
Medicine Department, two from the Anaesthesiology and In-
tensive Care Unit and one from the SurgeryDepartment. PT13
and PT14 each contained single C. sakazakii ST4 strains;
1839 and 1836, respectively. PT15 contained a single
C. sakazakii ST64 strain (1995). These strains were isolated
from a percutaneous endoscopic gastrostomy smear ICU,
wound surgery and the sputum of an outpatient, respectively.
The isolations were over a 7-month period and the patient ages
ranged from 50 to 73 years. PT7 consisted of seven
C. sakazakii ST4; strains 1840, 1916 and 2002 were isolated
from sputum, strain 2000 from rectal swab, strain 2001 from
oral cavity swab, strain 2009 from tongue swab and strain
2011 from section catheter. Six of the isolates were collected
from the Internal Medicine department, and strain 1840 was
isolated from an Intensive Care Unit patient. The collection
was over a 7-month period and all patients were over 68 years
of age. PT8, 9, 10 and 11 consisted of eight C. sakazakii ST4
strains. All these strains except one (1997) were isolated from
sputum at the Internal Medicine Department, whereas strain
1997 was collected from the Intensive Care Unit. The PT8
strain was isolated in 2013 from a 91-year-old patient. PT9
was isolated in 2013 from a 70-year-old patient. PT10 was
collected over a roughly 8-month period and the patient ages
were between 49 and 70 years old. The two strains in PT11
were collected in 2012 and 2013 and the mean patient age was
67 years (Table 4).
goeBURST analysis showed the range of patient ages and
sources with Cronobacter species (Fig. 2). C. sakazakii ST4
strains were predominantly sputum samples from adults
>70 years in age, whereas C. malonaticus ST7 were from
throat swabs of children <6 years old.
Discussion
Reported Cronobacter infections have primarily concerned
infants, especially premature neonates with clinical presenta-
tions of necrotising enterocolitis and invasive meningitis [21,
22]. Although many of these cases have been linked to con-
taminated reconstituted infant formula [23], other routes ap-
pear to exist, as infections occur in breast-fed infants as well
[22, 24, 25]. The carriage of the organism by adults [9] and the
high incidence of UTIs [6] indicate that the exposure routes to
this bacterium still require further elucidation. In order to have
a wider perspective on the exposure toCronobacter, this study
speciated and genotyped Cronobacter strains from age-
profiled clinical isolates, and extended the previous study by
Holý et al., who reported the incidence of Cronobacter from
>45,000 patients [9].
Of the 51 strains, the majority wereC. sakazakii (65%) and
C. malonaticus (33%) (Table 3). The prominence of these two
species in clinical isolates has been previously reported in a
review of the international Cronobacter PubMLST database
with >1000 strains (Forsythe et al. 2014) [10]. C. sakazakii
ST4 was the predominant sequence type (32/51 strains) and
composed all isolates from Prostějov hospital during a 1-year
period. Seventeen C. malonaticus ST7 strains were isolated
from two hospitals, Olomouc and Prostějov, during the 6-year
period from 2007 to 2013. Two further strains were identified
as ST64 and ST28, which are C. sakazakii and C. muytjensii,
respectively.
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PFGE analysis of isolates revealed that the 35 strains iso-
lated at Prostějov hospital could be divided into three groups.
The majority (32/35) of strains belonged to C. sakazakii ST4
and were serotype C. sakazakii O:2. These strains were isolat-
ed from various hospital departments during 2012–2013. Two
other group isolates were also recovered from patients in this
hospital. These were two strains of C. malonaticus ST7 and
were serotype C. malonaticus O:2, and were the only strains
isolated from the Department of Infectious Diseases. The re-
maining strain was C. sakazakii ST64 serotype O:2, which
was isolated from an outpatient (50 years old, sputum).
In contrast, all but one of the 16 Cronobacter strains iso-
lated from patients at Olomouc hospital were C. malonaticus
ST7 ; the other isolate was C. muytjensii. The C. malonaticus
strains belonged to the identical sequence type 7 and identical
serotype C. malonaticus O:2. With two exceptions, all these
strains were from patients at the Department of Paediatrics and
had an age range of 0–18 years. There were two strains from
adults, one C. malonaticus from an intravenous cannula and
another which was C. muytjensii from sputum.
Despite the greater discrimination of strains using PFGE
than MLST, isolates from patients for whom there were no
known links could not be further differentiated. For example,
the C. sakazakii ST4, pulsotype 12 strains were isolated from
15 adults (aged 27–85 years) between May 2012 and
May 2013. This could be due to the reported high clonality
of sequence types within C. sakazakii and C. malonaticus
limiting the discriminatory power of PFGE [1, 10].
In summary, these clinical isolates were predominated by
C. sakazakii ST4 (63 %, 32/51) and C. malonaticus ST7
(33 %, 17/51). These had been isolated from throat and spu-
tum samples of all age groups, as well as recal and faecal
Table 4 Distribution of Cronobacter species and genotype according to hospital and patient details
Cronobacter
species
Sequence
type
No. of
isolates (%)
Pulsotype (n) Hospital Period of isolation Age (years) Sex Source (n)
Male Female
C. sakazakii ST4 32 (63) 12 (15), 7 (7), 10 (4),
11 (2), 8 (1), 9 (1),
13 (1), 14 (1)
Prostějov 12/06/12–10/05/13 >27 16 16 Sputum (24), wound swab (2),
section catheter (1), tongue
swab (1), throat swab (1),
oral cavity (1), rectal swab (1),
SPEGa (1)
C. sakazakii ST64 1 (2) 15 (1) Prostějov 10/01/2013 50 1 0 Sputum (1)
C.malonaticus ST7 17 (33) 4 (6), 5 (5), 3 (3), 2 (1) Olomouc 06/05/07–16/08/13 <1 to 76 12 5 Throat swab (11), faecal material
(2), cannula (1), nasal swab (1)
1 (2) Prostějov 2/10/2012 & 5/05/2013 69 and 72 2 0 Sputum (2)
C. muytjensii ST28 1 (2) 6 (1) Olomouc 10/04/2012 63 0 1 Sputum (1)
Total 51 6 years 29 22
a SPEG Smear from area of percutaneous endoscopic gastrostomy
Fig. 2 goeBURST analysis of Cronobacter strains
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swabs. There was no apparent relatedness between the age or
sex of the patient and the Cronobacter species isolated. De-
spite the high clonality of Cronobacter, PFGE profiles differ-
entiated strains within each sequence type into 15 pulsotypes.
There was almost complete agreement between O-antigen
typing and rpoB gene sequence analysis and MLST profiling.
The majority (43/51) of strains were from the upper respira-
tory system (i.e. throat swabs and sputum samples) and only
three were from faeces and one from urine; two being
C. sakazakii ST4 and the remaining two C. malonaticus
ST7. Hence, it is plausible that this small sampling of the
lower intestinal tract and UTIs does not reflect the diversity
of Cronobacter in those samples. Given the high incidence of
Cronobacter in UTI, this area needs further consideration [6].
This study shows the value of applying MLST to bacterial
population studies with strains from two patient cohorts, com-
bined with PFGE for further discrimination of strains.
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